Summary The cell kinetics of 54 colorectal tumours were examined by immunohistochemical methods, using the monoclonal antibody DNA polymerase a which reacts with an antigen found only in proliferating cells. (Sasaki et al., 1977) . More recently, the proliferative index determined by flow cytometry (Barlogie et al., 1983; Lovett et al., 1984) or BrdU labelling index (BrdU is said to localise in cells in the S-phase) have been used to examine the cell kinetics of tumours (Gratzner, 1982) .
The proliferative potential of tumours is a useful index of their grade of malignancy. It is of paramount importance therefore to know the proliferative potential of a tumour both for choosing therapeutic methods and for predicting the prognosis. The 3H-thymidine labelling index or the mitotic index have so far been used for this purpose (Sasaki et al., 1977) . More recently, the proliferative index determined by flow cytometry (Barlogie et al., 1983; Lovett et al., 1984) or BrdU labelling index (BrdU is said to localise in cells in the S-phase) have been used to examine the cell kinetics of tumours (Gratzner, 1982) .
DNA polymerase ox is an enzyme playing a central role in DNA replication in mammalian cells (Weissbach, 1979; Sarngadharan et al., 1978) . The production of a monoclonal antibody against DNA polymerase a provided a new method for detecting proliferating cells (Bensch et al., 1982; Matsukage et al., 1982; Masaki et al., 1982; Tanaka et al., 1982; Yagura et al., 1987) . Bensch et al. (1982) demonstrated intranuclear distribution of the enzyme in human cells by immunohistochemical techniques with monoclonal antibodies against the human enzyme. In this study, the cell kinetics of large bowel tumours were examined with a monoclonal antibody against DNA polymerase a, to determine its usefulness as an index of the grade of malignancy of these tumours. (Table II) . (Table III) . In addition, the rate of DNA polymerase a positive cells was 55.1% in patients with liver metastasis, which was significantly higher than in cases without liver metasatasis (P< 0.01) (Table II) .
Materials and methods
In the 14 patients who had tumours with over 50% polymerase a positive cells, eight (57%) have proved to be inoperable.
Finally, 13 tumours (35.1%) were diploid and 24 (64.9%) were aneuploid. Table IV shows the relationship between the rate of DNA polymerase a positive cells and the DNA ploidy patterns. The rate was higher for lesions with the aneuploid pattern than for diploid lesions (P <0.05). Specifically, the percentage of DNA polymerase a positive cells was 39.8% for the diploid lesions and 46.6% for the aneuploid lesions. Aneuploid 24 46.6 + 9.1 1 * *P< 0.05.
Discussion
Recent reports have argued that the grade of malignancy of tumours varies with their biological characteristics. In other words, the grade of malignancy depends on the proliferative rate and the metastatic potential of a tumour. It is thus important to know the malignant grade of a tumour in choosing the therapeutic method and in predicting the prognosis. The 3H-thymidine labelling index has been used to learn the problems to be solved in determining the grade of malignancy before putting it into clinical application. In recent years, flow cytometry (Barlogie et al., 1983; Lovett et al., 1984) and a monoclonal antibody to BrdU (an analogue of thymidine) produced by Gatzner (1982) have been used in examining cell cycle kinetics. However, these methods involve a few problems in their clinical use. Ki-67, presumably a protein present in the nucleus of proliferating cells in the late G1, S, G2 and M phase (Gerdes et al., 1984) , may be an index of the malignancy grade of tumours because the rate of Ki-67 positive cells correlates with the histological grading when Ki-67 labelling is carried out in breast cancer, colorectal cancer and brain tumour (Gerdes et al., 1986; McGunin et al., 1987; Lelle et al., 1987; Burger et al., 1986; Yamaguchi et al., 1988) . However, recently Van Dierendonck et al. (1989) reported that Ki-67 fractions may not always be a reliable indicator of growth fraction. So in this study the cell kinetics of large bowel tumours were examined by the use of a monoclonal antibody against DNA polymerase a. Some literature has shown a marked rise in the level of DNA polymerase a when cells were stimulated to divide (Chang & Bollum, 1973; Baril et al., 1973) . DNA polymerase a, the major DNA polymerase in growing mammalian cells, is the most important enzyme in DNA replication (Weissbach, 1979; Sarngadharan et al., 1978) . It is believe that DNA polymerase a localises in the nucleus of proliferative cells in the G1, S and G2 phases of transformed human cells, and shows a scattered cytoplasmic distribution in M phase of the cell cycle, but that it is not found in resting cells (Bensch et al., 1982; Matsukage et al., 1983; Nakamura et al., 1984) . The monoclonal antibody against DNA polymerase a which we have used was reported by Masaki et al. in 1982. This antibody recognises a nuclear antigen which is expressed in cycling cells. So the detection of DNA polymerase a seems to be effective for estimating the proliferative activity of cells. It has been reported that DNA polymerase a was detected using the monoclonal antibody in normal and neoplastic tissue of the uterine cervix (Mushika et al., 1988) . No report has been available to date on the cell kinetics of gastrointestinal tumours using this method of investigation. In this study, we found that some normal cell nuclei showed a DNA polymerase a positive pattern in the zone adjacent to the tumours. The rate of DNA polymerase a positive cells in adenoma was 24.5% on average, but the rate for colorectal cancer was a much higher (44.8% on average). In relation to the DNA ploidy pattern, the rate of DNA polymerase a positive cells for aneuploid lesions was higher than for those with a diploid pattern. It has been said that tumour DNA content is an independent prognostic indicator in patients with colorectal cancer (Wolley et al., 1982; Scott et al., 1987; Kokal et al., 1986; Armitage et al., 1985) . The correlation of DNA polymerase a staining with the DNA ploidy pattern suggests the usefulness of DNA polymerase a positive cells rate in judging the malignancy grade of carcinoma.
The DNA polymerase a positive cells rate was histopathologically examined in large bowel cancer lesions. The results revealed that the ratio of positive cells was increased as the degree of differentiation of cancer decreased. For patients with total invasion of the large bowel wall, the rate of DNA polymerase a positive cells was higher than for those with partial invasion of large bowel wall, and the rate of DNA polymerase a positive cells also correlated with the presence of venous invasion or liver metastasis. In other words, the rate of antibody positivity seemed to allow the rate of proliferating cells to be estimated, thus helping to predict the tendency for invasion and the proliferative potential of the tumours. Although this study was retrospective in nature, the rate of DNA polymerase a positive cells can also be analysed with biopsy specimens. Thus, DNA polymerase a positive cell rate may possibly be a useful prognostic marker for colorectal cancers.
